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ABSTRACT
Obstructive sleep apnea (OSA) is a common type of sleep apnea and is caused by obstruction of upper airway. Sleep 
apnea is clinically defined as frequent episodes of apnea, hypopnea and symptoms of functional impairment, which could 
be life-threatening and associated with extreme daytime hyper somnolence, dysfunction, discrements in health-related 
quality of life, automobile accidents, and cardiovascular morbidity and mortality. Etiopathogenic factors that contribute 
to OSA include reduced upper-airway dilator muscle activity during sleep, upper-airway anatomical features, ventilatory 
control insufficiency, lung volume, and rostral fluid shifts. The presence of risk factors such as age, gender and obesity 
increases the incidence of OSA. The repetitive nocturnal hypoxemia experienced by patients with OSA is associated 
with activation of a number of neural, humoral, thrombotic, metabolic, and inflammatory disease mechanisms, all of 
which have also been implicated in the pathophysiology of various systemic diseases. This article summarizes the 
etiopathogenesis, epidemiology, associated systemic diseases such as cardiovascular diseases, diabetes, and dental 
diseases with OSA and the influence of tongue on oropharyngeal airway in OSA patients.
Key words: Apnea, breathlessness, snoring
Date of Acceptance: 16-Jan-2014
Address for correspondence:  
Dr. Aarthy Viswanath,  
13/1B, Jain Sunderbans, Nolambur, Chennai - 600 090,  
Tamil Nadu, India.  
E-mail: aarthyviswanath@gmail.com
Introduction
“Sleep disorder breathing” (SDB) is a term, which includes 
simple snoring, upper‑airway resistance syndrome, and 
sleep apnea.[1] Sleep apnea is clinically defined as frequent 
episodes of apnea (cessations) and hypopnea (discrete 
reductions) and symptoms of functional impairment, which 
could be life threatening and associated with extreme 
daytime hyper somnolence, dysfunction, discrements in 
health related quality of life, automobile accidents, and 
cardiovascular morbidity and mortality.[2] Sleep apnea is 
the most prevalent of all the upper‑airway disorders and 
is classified as central, obstructive and mixed or mild, 
moderate and severe.[3] Obstructive sleep apnea (OSA) is a 
disorder characterized by repetitive collapse and reopening 
of the upper airway during sleep, which impairs ventilation 
and can result in intermittent hypoxemia and hypercapnia.[4]
Obstructive sleep apnea is insidious and patients are 
often unaware of the associated symptoms. Cardinal 
manifestations include loud snoring, witnessed breathing 
pauses during sleep, fitful sleep quality, fatigue, dry mouth, 
morning headache, and excessive daytime sleepiness (EDS). 
Early recognition and appropriate therapy can ameliorate 
the neurobehavioral consequences.[5]
Etiopathogenic factors that contribute to OSA includes 
reduced upper‑airway dilator muscle activity during sleep,[6] 
upper‑airway anatomical features,[7] ventilatory control 
insufficiency,[8] lung volume,[9] and rostral fluid shifts.[10,11]
Age,[12] gender,[13] and obesity[14] are interrelated in a complex 
manner and considered to be a risk factor for incidence 
of OSA. The cutoff value of body mass index (BMI) for 
obesity in the Caucasian populations is at 30 kg/m2, but 
some Asian‑Indian populations have redefined obesity at 
a lower BMI of 23 kg/m2 for both the sexes.[15] The World 
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Health Organization (WHO) task force on obesity suggested 
that Asian‑Indian populations have different associations 
between BMI, percentage of body fat, and health risks than 
do Caucasians (WHO, 2000). Clinically, neck circumference 
has been reported to be a useful predictor of OSA.[16]
Several anatomic factors predisposes to the development 
of OSA, which includes size of the tongue and craniofacial 
morphology.[17] In adult snorers and OSA patients, there is a 
good correlation between clinical tonsil grade and objective 
tonsil volume.[18] According to Nuckton et al. (2006), the 
Mallampati score is an independent predictor of OSA and 
its severity.[19]
There is a robust association between OSA and systemic 
conditions such as cardiovascular diseases such as 
hypertension (HT) and diabetes mellitus (DM), which are 
the main health problems in both developed and developing 
countries. Patients with HT are nearly 2.5 times more likely 
to develop OSA.[20] In patients with drug resistant HT 
an even higher OSA prevalence of 83%[21] is seen. HT is 
defined as blood pressure at least 140/90 mmHg.[20]
Until date, four studies including a total number of nearly 




According to the American Academy of Sleep Medicine 
recommendations, OSA is defined with apnea‑hypopnea 
index (AHI) >5 or AHI ≥ 5 and associated with symptoms 
such as EDS, impaired cognition, mood disorders, insomnia, 
HT, ischemic heart disease, or history of stroke.[26,27] OSA 
is a disturbance in normal sleep patterns; when combined 
with daytime symptoms, this condition is termed “OSA 
syndrome”.[28‑30]
Prevalence estimates of disturbed sleep range from 35% 
to 41% among adults, out of which the most common 
sleep disturbances is OSA, followed by the frequent 
snoring, difficulty initiating or maintaining sleep (insomnia 
symptoms), and EDS.[31]
Etiopathogenesis of obstructive sleep apnea
The most common factors that are known to contribute 
to the etiopathogenesis of OSA, are upper‑airway dilator 
muscle activity during sleep, upper‑airway anatomy, lung 
volume, ventilatory control instability, sleep state stability, 
and rostral fluid shifts.[11]
Upper‑airway dilator muscle activity
The largest of the pharyngeal dilator muscles is the 
genioglossus, the muscle that forms the majority of the 
body of the tongue[32] and its function can be augmented in 
response to heightened airway resistance and hypercapnia 
through inputs from[6,33] the sleep/awake centers of the brain, 
respiratory pattern generating neurons, chromoreceptors, 
and negative pressure receptors in the airway that can 
modify its activity.[6,34]
Upper‑airway anatomy
Anatomical factors, including increased airway length, 
lateral wall thickness, and tongue volume, are associated 
with the presence of OSA.[35] A small maxilla or mandible 
can result in a reduced airway size.[7]
Lung volume
Lower end‑expiratory lung volume, increases the tendency 
of the upper‑airway collapse.[36] A continuous positive airway 
pressure (CPAP) level is necessary to maintain airway 
patency, and to reduce the severity of OSA.[9,37]
Ventilatory control instability
Persons with OSA generally have greater instability of 
ventilatory control and higher loop gain than healthy 
individuals.[38] Since upper‑airway muscles receive input 
from respiratory control centers, unstable ventilatory 
control will cause greater fluctuation in the activity of 
the upper‑airway muscles and promote upper‑airway 
collapse.[8,33]
Fluid shifts
Fluid shifts from the legs to the neck appear to play a role in 
pathogenesis of OSA. Overnight rostral fluid displacement 
from the legs correlates strongly with AHI, change in neck 
circumference.[10] Furthermore, time spent in sitting was 
a significant risk factor even in non‑obese, healthy men 
suspected of having OSA.[10,39,40]
Genetics
Evidence from racial, familial, and twin studies indicates 
that OSA has a strong genetic basis.[41] There is an evidence 
that the genetic determinants present for upper‑airway 
muscles activity, skeletal structures, obesity, epidemiology 
of fat distribution and respiratory control may interact to 
cause OSA. The role of specific genes in the pathogenesis 
remains to be elucidated.[42]
Epidemiology of obstructive sleep apnea
Gender and age on obstructive sleep apnea
Several investigators have reported gender differences in 
the abnormalities of nocturnal respiration. In the widely 
quoted Wisconsin Sleep Cohort Study, the prevalence of 
sleep disordered breathing in men (24%) is almost three 
times higher than in the women (9%).[13,43] The reason for 
the gender differences in the prevalence and severity of 
sleep apnea are multifactorial, and is primarily attributed to 
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difference in fat distribution,[44] and structural differences 
in upper‑airway dimensions.[34] Percentage of neck fat 
in Women and percentage abdominal fat in men, were 
significant predictors of AHI severity in the sexes.[44] The 
prevalence of snoring is correlated with BMI independent 
of menstrual status, and lower BMI is a protective factor 
against snoring in premenopausal women.[45] Therefore, BMI 
is an independent risk factor for OSA in women.
OSA remains highly prevalent among the elderly;[46,47] the 
prevalence of at least moderate OSA varies widely from as 
low as 7% to as high as 44%.[48] It has been shown that the 
BMI had a smaller influence on the AHI in the elderly when 
compared with the middle aged individuals[12,48,49]
Obstructive sleep apnea and obesity
Obesity develops from an imbalance of energy over time, 
when energy intake exceeds energy expenditure, leading 
to accumulation of adipose tissue with a corresponding 
increase in lean body mass.[50] Patients with mild OSA who 
gain 10% of their baseline weight are at a six‑fold increased 
risk of progression of OSA, and an equivalent weight loss 
can result in a more than 20% improvement in severity 
of OSA.[51] Fat deposition in the tissues surrounding the 
upper airway appears to result in a smaller lumen and 
increased collapsibility, predisposing to apnea.[14] Moreover, 
fat deposits around the thorax (truncal obesity) reduce 
chest compliance and functional residual capacity, and 
may increase oxygen demand.[52‑54] Factors such as reduced 
activity levels and increased appetite, particularly for refined 
carbohydrates, may conceivably contribute to weight gain 
in OSA patients. Current evidence based studies suggest 
that OSA may itself cause weight gain.[14,55]
The cutoff value of BMI for obesity in the Caucasian 
populations is at 30 kg/m2, but some Asian‑Indian 
populations have redefined obesity at a lower BMI of 
23 kg/m2 for both the sexes.[15] The WHO task force on 
obesity suggested that Asian‑Indian populations have 
different associations between BMI, percentage of body 
fat, and health risks than do Caucasians (WHO, 2000). 
Clinically, neck circumference has been reported to be a 
useful predictor of OSA,[16] however the exact role of neck 
circumference in the development of OSA has not been 
fully clarified.[56]
Obesity is a major modifiable risk factor for OSA,[57,58] weight 
loss is recommended for all overweight or obese patients 
with sleep apnea, as its beneficial effects embrace other 
obesity related health problems, notably cardiometabolic 
diseases.[50,59]
Obstructive sleep apnea and craniofacial morphology
Craniofacial characteristics associated with OSA include 
aspects of skeletal morphology pertaining to the mandible, 
maxilla, cranial base, hyoid, and head position,[7] as well 
as soft tissue morphology relating to size of upper‑airway 
soft tissues.[54] Aspects of skeletal craniofacial morphology 
relating to OSA have been explored primarily using 
cephalometric analysis.[7] Most common predictors include 
differences in maxillary mandibular morphology and its 
relationship. In terms of the maxilla, a shorter length and 
also narrower[60] and more tapered maxillary arch[50,61] 
and mandibular deficiency has also been associated with 
OSA patients. Three‑dimensional imaging techniques have 
also confirmed, a smaller mandibular enclosure areas seen 
in OSA subjects.[50]
The lowered hyoid position is also been considered as 
confounding factors for OSA patients.[62]
Obstructive sleep apnea and cardiovascular diseases
The strong association between OSA and HT[63] has 
attracted considerable attention in recent years. HT is 
defined as taking antihypertensive without regard to the 
actual measurement of blood pressure, or having a systolic 
blood pressure reading greater than 140 mm Hg or a diastolic 
blood pressure reading greater than 90 mm Hg.[64]
Pathophysiology
Three key pathophyiological features of OSA that give rise 
to these abnormal cardiovascular oscillations are:
a. Generation of exaggerated negative intrathoracic 
pressure against the occluded pharynx
b. hypoxia and
c. arousals from sleep.
a. Negative intrathoracic pressure against the occluded 
pharynx: Ineffective inspiratory efforts are a hallmark 
of obstructive apneas. The resulting exaggerated 
negative intrathoracic pressure swings increase left 
ventricular (LV) transmural pressure by increasing 
the difference between extra cardiac and intracardiac 
pressures, and hence after load, but without increasing 
Blood Pressure (BP). It also increases venous return 
to the right ventricle, leading to its distention. The 
resulting leftward shift of the interventricular septum 
can impede LV diastolic filling. There is also evidence 
that exaggerated negative intrathoracic pressure during 
apnea can impair LV relaxation, which could further 
impede LV filling.[65] The combination of increased LV 
after load and reduced LV preload leads to a reduction 
in stroke volume during obstructive apneas that is 
proportional to the negative intrathoracic pressure 
generated.[66]
b. Hypoxia: During obstructive apneas, the sympatho 
excitatory effect of hypoxia is amplified by apnea and 
CO2 retention.
[67] This result in increased sympathetic 
vasoconstrictor tones however; these sympatho 
excitatory effects are not engaged until several seconds 
into the apnea. Intermittent hypoxia during obstructive 
apneas may directly depress cardiac contractility, or 
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reduce cardiac performance indirectly by causing 
pulmonary vasoconstriction and increasing pulmonary 
arterial pressure.[63] The degree of desaturation during 
each obstructive apnea has been directly related to the 
magnitude of the increase in BP following the apnea.[9]
c. Arousals: Arousal is a critical defense mechanism 
that makes active upper‑airway dilator muscles and 
prevents asphyxiation in OSA. Arousals causes only a 
small further increment in heart rate (HR) and blood 
pressure (BP).[68] One confounding factor is that arousals 
are accompanied by an abrupt increase in ventilation 
that precedes increases in HR and BP. This suggests 
that the increased ventilatory drive at termination of 
apnea coactivates cardiovascular sympathetic neurons 
that are closely linked with respiratory neurons in the 
brainstem.[66,69]
d. Correlation of HT and OSA: Patients with HT are 
nearly 2.5 times more likely to develop OSA.[20] In 
patients with drug resistant HT an even higher OSA 
prevalence of 83%[21] is seen and has been reported 
that SDB and HT is seen in both sexes and all 
ethnic groups and are slightly stronger among those 
who are overweight or obese.[44,70] The hypothesis 
of a causal association between sleep apnea and HT 
is supported by evidence from intervention trials, 
showing that successful treatment of sleep apnea 
by means of weight loss; CPAP is accompanied by 
significant decreases in both daytime and nighttime 
blood pressure.[71] SDB is more prevalent in men with 
HT than in normal individuals without HT.[72] Several 
studies have proposed hemodynamic disturbances due 
to OSA resulting in abnormal activation of arterial 
chemoreceptors and increased sympathetic activity, 
followed by arousals during sleep.[57,73]
Metabolic syndrome and obstructive sleep apnea
Metabolic syndrome (MS) is strongly linked to obesity and 
comprises of multiple metabolic abnormalities, such as HT, 
insulin resistance, central obesity, and dyslipidemia. Current 
data suggest that there is an increased prevalence of MS in 
subjects with OSA.[24,53]
The MS is also known as insulin resistance syndrome. 
The constellation of metabolic derangement includes 
insulin resistance/glucose intolerance, central obesity, 
HT, and dyslipidemia, which are well‑known risk factors 
for cardiometabolic diseases.[74] Several studies has been 
indicated that MS predicts future diabetes as well as an 
increased risk of cardiovascular disease and all causes of 
mortality.[53,75,76]
Pathophysiology of MS is still a subject of debate, and 
both visceral obesity and insulin resistance appear to be 
the predominant drivers of this syndrome. It has been 
proposed that visceral fat probably plays a role in the hepatic 
manifestations of central obesity[55] and systemic free fatty 
acid concentrations are found to affect muscle, pancreatic β 
cells, and vascular functions at molecular level. The current 
status stated that visceral fat is particularly damaging and 
is of greater risk for DM, cardiovascular disease and certain 
cancers.[53,77]
Prevalence of obstructive sleep apnea in type 2 diabetics
The prevalence of OSA in patients with type 2 diabetes 
was assessed by methods other than the gold standard full 
polysomnography (PSG) (e.g, limited PSG or overnight 
oximetry), should variable estimate ranging from 2 to 70%.
Until date, four studies including a total number of nearly 
900 type 2 diabetic patients have reported a striking overall 
prevalence of 73%,[22,23,25] reported an OSA prevalence of 
77% in 60 type 2 diabetics (Mean Age: 57 years) using a 
less stringent cutoff of 3% for oxygen desaturations, and 
when the dataset was reanalyzed using a stricter 4% criteria, 
this estimate decreased to 58%. Considering that the 
prevalence of OSA by full‑night PSG in patients with type 2 
diabetes averages 73%, this would then suggest that nearly 
17 million diabetics currently suffer from this unrecognized 
comorbidity.[5]
Prevalence of type 2 diabetes in obstructive sleep apnea
In cross‑sectional analyses, it has been demonstrated that 
there is a significantly higher prevalence of DM in patients 
with OSA as compared to those without OSA.[24] The 
Busselton health study found a significant independent 
association between moderate to severe OSA and incident 
DM over a 4‑year follow‑up period, but the sample size was 
small and there were only few incident cases of diabetes, 
which resulted in a wide confidence interval.[77] The 
prevalence of undiagnosed obstructive OSA is high among 
patients with poorly controlled type 2 diabetes[78] and that 
it is mainly related to visceral obesity. Furthermore, we 
have found that the presence of obstructive OSA cannot 
be predicted by clinical data, which suggests that OSA 
should be systematically screened for in such a patient 
population.[79]
In summary, future studies from large longitudinal cohorts 
are clearly needed to assess the role of OSA as a potential 
risk factor for diabetes.[77]
Dental predisposing factors and obstructive 
sleep apnea
Influence of tongue on oropharyngeal airway in 
obstructive sleep apnea patients
Cephalometric analysis in patients with OSA and healthy 
controls, reported that the non‑obese patients with OSA 
showed enlarged tongue[55] and inferior shift of the tongue 
volume,[18] in comparison with their BMI matched healthy 
controls.
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The upper‑a i rway  so f t  t i s sue  s t ructures  were 
three‑dimensionally analyzed with an advanced analysis 
technique through magnetic resonance imaging and Shigeta 
et al. stated that the volume of the tongue and lateral walls 
independently increases the risk of sleep apnea. There 
is a significant positive correlation between BMI and 
tongue volume,[7] and a significant negative correlation 
between BMI and airway volume[80] and also there is a 
negative correlation between airway volume and tongue 
and mandible (T/M) ratio. As tongue volume increases 
with BMI, the T/M ratio is affected, and thus is likely to be 
involved in the development of OSA.[80]
Influence of tonsil volume and uvula size on obstructive 
sleep apnea patients
The role of thickened and exceedingly collapsible lateral 
pharyngeal walls in the pathophysiology of OSA is well 
recognized in adults.[18,35]
According to Force et al. (2009); tonsils are subjectively 
measured using a grading system in which grade I represents; 
tonsils are hidden in the tonsillar fossa and barely visible 
behind the anterior pillars. In grade II, the tonsils are visible 
behind the anterior pillars and occupied up to 50% of the 
pharyngeal space (the distance between the medial borders 
of the anterior pillars). In grade III, the tonsils occupied 
between 50 and 75% of the pharyngeal space. In grade IV, the 
tonsils occupied more than 75% of the pharyngeal space.[4]
In Mallampati’s technique,[19] with the tongue kept in place 
without the use of a tongue depressor, grade 1, represents 
the tonsils, pillars, pharynx, and soft palate are clearly 
visible; grade 2, the uvula and only the upper part of the 
pillars and tonsils are visible between the palate and the 
tongue; grade 3, only the soft and hard palate are visible, 
whereas the tonsils, pillars, pharynx and base of the uvula 
are hidden behind the tongue. In grade 4, only the hard 
palate is visible.[30] The Mallampati score is an independent 
predictor of OSA and its severity.[19]
In adult snorers and OSA patients, there is a good 
correlation between clinical tonsil grade and objective tonsil 
volume.[18] The clinical ability to infer tonsil volume is not 
impaired by possible changes in pharyngeal geometry that 
are related to OSA.[4] Although tonsil volume correlates 
with AHI, from a clinical perspective, only tonsil grade IV 
predicts severe OSA. Pharyngeal tissue volume likely reflects 
BMI rather than OSA.[18]
Conclusion
Obstructive sleep apnea is gaining lots of importance in 
the recent years due to its impact on various systems of 
our body. It has been considered as a Pandemic disease. 
We conclude that snoring and sleep apnea are common 
among Indian adults. Recognition of the importance of 
OSA among general public would be a valuable step toward 
implementing population‑based strategies to reduce OSA 
prevalence. Various studies have showed sex, higher BMI, 
and presence of HT is considered as risk factors for OSA. 
Therefore, early detection and treatment of OSA may be 
essential with intervention to reduce risk of associated 
medical problems.
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